Source: Sprim Als Blog

Sprim Als Blog SPRIM PRO Announces a Novel and Validated Approach for Monitoring Infant Growth from Home in Clinical Trials, Reducing Burdens on Caregivers and Clinical Sites

September 24, 2024, SPRIM PRO - SPRIM PRO, a CRO renowned for its innovative approach to clinical trials and healthcare, is excited to announce its accepted, peer reviewed publication in Frontiers in Pediatrics medical journal entitled, "Assessment of the reliability ... Read More  The post SPRIM PRO Announces a Novel and Validated Approach for Monitoring Infant Growth from Home in Clinical Trials, Reducing Burdens on Caregivers and Clinical Sites appeared first on SPRIM.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
Michael Shleifer's photo - Managing Partner of Sprim Als

Managing Partner

Michael Shleifer

CEO Approval Rating

72/100

Read more